Under kliniske studier med CEPROTIN blev der rapporteret 6 ikke- alvorlige bivirkninger (ADRer) hos 3 ud af 225 inkluderede patienter.
During clinical studies with CEPROTIN, a total of 6 non-serious adverse drug reactions (ADRs) were reported in 3 of 225 patients enrolled.